Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2022-09-19 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于控股子公司2022年度第九期超短期融资券发行结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the issuance results of a short-term financing bond by a subsidiary of the company. It includes details such as issuance amount, interest rate, dates, and registration information. There is no indication that this is a full financial report or an earnings release. The content focuses on capital raising activity and financing details. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is short and it is not merely announcing the publication of a report but providing substantive issuance details.
2022-09-19 Chinese
关于控股股东部分股份被司法冻结的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the judicial freezing of shares held by the company's controlling shareholder. It details the number of shares frozen, the reasons, and the impact on the company. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. The document is a regulatory announcement about shareholding status and legal restrictions on shares. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit into more specific categories like Major Shareholding Notification (MRQ) because it concerns judicial freezing rather than ownership threshold changes.
2022-09-08 Chinese
关于控股子公司向专业投资者公开发行可续期公司债券获中国证监会同意注册批复的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the approval from the China Securities Regulatory Commission (CSRC) for the company's subsidiary to publicly issue perpetual corporate bonds to professional investors. It references financing plans, board and shareholder meeting approvals, and regulatory registration approval. The content focuses on financing activities and regulatory consent for bond issuance, without containing financial statements or detailed financial results. The document length is short (902 characters) and it is an announcement of a financing approval rather than a full financing report or detailed financial disclosure. Therefore, it fits best under Capital/Financing Update (CAP).
2022-08-26 Chinese
独立董事关于公司第八届董事会第八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from the independent directors of a company regarding specific matters discussed at a board meeting, including a risk assessment report and the appointment of a board secretary. It references compliance with company law, securities law, and stock exchange rules. The content focuses on governance and board-related decisions rather than financial results or audit findings. The document length is short (740 characters), and it is not a full report but an opinion related to board matters. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2022-08-25 Chinese
2022年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "重药控股股份有限公司2022 年半年度报告全文" which translates to "C.Q. Pharmaceutical Holding Co., Ltd. 2022 Semi-Annual Report Full Text." It contains detailed financial data, management discussion and analysis, company overview, financial indicators, and other comprehensive information typical of an interim or quarterly report. The report period is explicitly stated as January 1, 2022 to June 30, 2022, confirming it covers a half-year period. The document length is substantial (15,000 characters), and it includes actual financial statements and substantive financial data, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-25 Chinese
2022年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2022 半年度报告摘要' which translates to '2022 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also includes shareholder information and notes on changes in controlling shareholders. The presence of comprehensive financial figures and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 5886 characters, which is sufficient to contain substantive financial data, not just an announcement or summary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.